Calidi Biotherapeutics Management
Management criteria checks 4/4
Calidi Biotherapeutics' CEO is Allan Camaisa, appointed in Feb 2018, has a tenure of 6.5 years. total yearly compensation is $436.51K, comprised of 58.9% salary and 41.1% bonuses, including company stock and options. directly owns 12.6% of the company’s shares, worth $1.56M. The average tenure of the management team and the board of directors is 4.7 years and 4.1 years respectively.
Key information
Allan Camaisa
Chief executive officer
US$436.5k
Total compensation
| CEO salary percentage | 58.9% |
| CEO tenure | 6.5yrs |
| CEO ownership | 12.6% |
| Management average tenure | 4.7yrs |
| Board average tenure | 4.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$30m |
| Dec 31 2023 | US$437k | US$257k | -US$29m |
| Sep 30 2023 | n/a | n/a | -US$29m |
| Jun 30 2023 | n/a | n/a | -US$32m |
| Mar 31 2023 | n/a | n/a | -US$24m |
| Dec 31 2022 | US$2m | US$43k | -US$25m |
| Sep 30 2022 | n/a | n/a | -US$21m |
| Dec 31 2021 | US$1m | US$26k | -US$11m |
Compensation vs Market: Allan's total compensation ($USD436.51K) is below average for companies of similar size in the US market ($USD691.65K).
Compensation vs Earnings: Allan's compensation has been consistent with company performance over the past year.
CEO
Allan Camaisa (63 yo)
6.5yrs
Tenure
US$436,512
Compensation
Mr. Allan J. Camaisa serves as Chief Executive Officer and Chairman of the Board at Calidi Biotherapeutics, Inc since February 2018. He served as Chief Executive Officer and Chairman at Parallel 6, Inc. si...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of the Board | 6.5yrs | US$436.51k | 12.6% $ 1.6m | |
| Chief Administrative Officer | 2.9yrs | US$295.40k | 0.23% $ 28.3k | |
| President of Medical & Scientific Affairs and Interim Chief Medical Officer | 9.2yrs | US$400.10k | 0.60% $ 73.9k | |
| Chief Financial Officer | less than a year | no data | no data | |
| Senior Vice President of Technical Operations | 2yrs | no data | 0.041% $ 5.1k | |
| Chief Business Officer | 8.6yrs | no data | 0.66% $ 82.0k |
4.7yrs
Average Tenure
56.5yo
Average Age
Experienced Management: CLDI's management team is considered experienced (4.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of the Board | 6.5yrs | US$436.51k | 12.6% $ 1.6m | |
| Independent Director | 4.1yrs | US$109.56k | 1.6% $ 198.6k | |
| Member of Medical Advisory Board | 2.2yrs | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Independent Vice-Chairman of the Board | 5.3yrs | US$179.89k | 3.48% $ 431.3k | |
| Independent Director | less than a year | US$120.56k | 0.22% $ 26.8k | |
| Director | 4.8yrs | US$983.14k | 0.039% $ 4.9k | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 3.6yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data |
4.1yrs
Average Tenure
63yo
Average Age
Experienced Board: CLDI's board of directors are considered experienced (4.1 years average tenure).